









Markets
/
Stocks
/
nasdaq-vero
/

Venus Concept Inc

VERO

1.140USD

-0.040-3.39%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

2.12MMarket Cap

LossP/E TTM



Venus Concept Inc

1.140

-0.040-3.39%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Venus Concept Inc

Currency: USD Updated: 2026-02-06

Key Insights

Venus Concept Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 142 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 0.00.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Venus Concept Inc's Score

Industry at a Glance

Industry Ranking

142 / 205

Overall Ranking

449 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Venus Concept Inc Highlights

StrengthsRisks

Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.

Growing

The company is in a growing phase, with the latest annual income totaling USD 64.83M.

Overvalued

The company’s latest PE is -0.03, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 298.27K shares, increasing 25.57% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 2.03K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.97.

Analyst Rating

Based on 2 analysts

Hold

Current Rating

0.000

Target Price

0.00%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Venus Concept Inc is 5.95, ranking 180 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 13.78M, representing a year-over-year decrease of 8.20%, while its net profit experienced a year-over-year decrease of 143.00%.

Score

Industry at a Glance

Previous score

5.95

Change



Financials

4.29

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.65

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.04

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.69

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.07

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Venus Concept Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Venus Concept Inc is 7.60, ranking 73 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.03, which is -17.31% below the recent high of -0.02 and -22370.32% above the recent low of -6.36.

Score

Industry at a Glance

Previous score

7.60

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 142/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

No earnings forecast score is currently available for Venus Concept Inc. The Healthcare Equipment & Supplies industry's average is 7.77.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 2 analysts

Hold

Current Rating

0.000

Target Price

0.00%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Venus Concept Inc

VERO

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Venus Concept Inc is 6.46, ranking 143 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 9.03 and the support level at -2.84, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.47

Change

-0.01

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.206

Sell

RSI(14)

44.864

Neutral

STOCH(KDJ)(9,3,3)

13.137

Oversold

ATR(14)

0.694

Low Volatility

CCI(14)

-70.804

Neutral

Williams %R

98.123

Oversold

TRIX(12,20)

-1.419

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

1.278

Sell

MA10

1.314

Sell

MA20

1.906

Sell

MA50

1.835

Sell

MA100

2.010

Sell

MA200

2.224

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Venus Concept Inc is 3.00, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 16.04%, representing a quarter-over-quarter increase of 16.40%. The largest institutional shareholder is The Vanguard, holding a total of 2.03K shares, representing 0.11% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Orca Capital GmbH

101.75K

EW Healthcare Partners

99.02K

HealthQuest Capital Management, L.P

41.19K

DRW Securities, LLC

29.66K

Madryn Asset Management, LP

10.19K

De Silva (Rajiv)

7.58K

Geode Capital Management, L.L.C.

6.12K

UBS Financial Services, Inc.

7.79K

The Vanguard Group, Inc.

Star Investors

2.03K

Tower Research Capital LLC

1.94K

-50.45%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Venus Concept Inc is 1.57, ranking 183 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is -0.07. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.